US Edition
Nick Challoner appointed CEO of Ingenza to drive further growth - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Nick Challoner appointed CEO of Ingenza to drive further growth - Pharmafile
Ingenza, a Scottish contract research, development and manufacturing organisation (CRDMO), has announced the appointment of Nick Challoner as chief executive officer, effective October 2025. With over three decades of leadership in chemical and biotech industries, Challoner’s arrival marks a key milestone in Ingenza’s growth strategy. Challoner most recently served as group chief scientific officer at […] The post Nick Challoner appointed CEO of…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
